Aspirin Is Associated with Improved Survival in Severely Thrombocytopenic Cancer Patients with Acute Myocardial Infarction

BACKGROUND. Patients with hematologic malignancies are at risk for severe thrombocytopenia (sTP). The risk and benefit of aspirin are not known in thrombocytopenic cancer patients experiencing acute myocardial infarction (AMI). MATERIALS AND METHODS. Medical records of patients with hematologic mali...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncologist
Hlavní autoři: Feher, Attila, Kampaktsis, Polydoros N., Parameswaran, Rekha, Stein, Eytan M., Steingart, Richard, Gupta, Dipti
Médium: Artigo
Jazyk:Inglês
Vydáno: AlphaMed Press 2017
Témata:
Hematologic Malignancies
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5330698/
https://ncbi.nlm.nih.gov/pubmed/28159866
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0110
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky